# Olympus invests in Medi-Tate for BPH devices

Olympus entered into a final agreement with Medi-Tate Ltd., an Israeli medical device manufacturer, including distribution rights and an option to acquire 100% of the company. The investment strengthens Olympus's urology business.

- Type: Investment
- Announced: 2018-11-07
- Where: Israel
- Status: announced
- Products: iTind device for Benign Prostatic Hyperplasia
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Olympus](https://endata.com/companies/30528.md) (investor)
- [Medi-Tate](https://endata.com/companies/35296.md) (target)

## Sources

- [medical.olympusamerica.com](https://medical.olympusamerica.com/articles/olympus-announces-investment-israeli-based-manufacturer-minimally-invasive-benign-prostatic), 2018-11-07: "The agreement includes the right for Olympus to distribute Medi-Tate’s products and an option that, in the future if exercised, allows Olympus to acquire 100% of the company."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.